RxDoctor Payments Data

Lauren Bandy

Psychiatric/Mental Health · Abbeville, LANPI 1508347469

Payments from drug & device makers

$6,061in general payments, 2019–2025

Across 352 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Axsome Therapeutics, Inc.$706
  • Sunovion Pharmaceuticals Inc.$369
  • Vanda Pharmaceuticals Inc.$321
  • plus $996 from 15 others

What the payments were for

  • Food & beverage$6,049100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,061 in reported general payments places this provider in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl111$162,877
RexultiBrexpiprazole98$155,960
CaplytaLumateperone Tosylate69$120,156
Invega SustennaPaliperidone Palmitate21$68,109
Abilify MaintenaAripiprazole19$52,183
AristadaAripiprazole Lauroxil12$36,387
Lurasidone Hcl126$15,689
Aripiprazole151$7,374
TegretolCarbamazepine12$5,132
Oxcarbazepine129$4,217
Lisdexamfetamine Dimesylate20$4,128
Quetiapine Fumarate320$4,060
Duloxetine Hcl190$3,837
Vilazodone Hcl24$3,674
Methylphenidate ErMethylphenidate Hcl12$3,568

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$232$208,144117 claims
AbbVieVraylar$1,442$162,877111 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,066$120,15669 claims
Johnson & JohnsonInvega Sustenna$28$68,10921 claims
Alkermes, Inc.Aristada$1,160$36,38712 claims
Lilly USA, LLCOlanzapine$60$70176 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Abbeville

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →